Table 3.
Drug use among study population
| Type of therapy | Proportion of patients* |
|---|---|
|
Diet alone |
15.0% |
|
Glucose lowering therapy |
|
| Metformin |
64.5% |
| Sulphonylurea |
54.5% |
| Glitazone |
0.5% |
| Gliptin |
0.1% |
| Insulin |
1.6% |
|
Anti-hypertensives |
|
| None |
35.4% |
| ACEI or ARB |
38.2% |
| β-blocker |
26.6% |
| CCB |
41.8% |
| Diuretic |
13.2% |
|
Lipid lowering therapy |
|
| Statin |
22.2% |
| Fibrate |
3.7% |
| Aspirin | 9.4% |
ACEI: angiotensin converting enzyme inhibitor.
ARB: angiotensin receptor blocker.
CCB: calcium channel blocker.
*Percentages do not add up to 100% because some patients may be taking more than one therapy.